DNY-13790-91714
5 vaccinations
7 coded responses
52 check-ins
5 free-text entries
4 call cases
- Sex
- Female
- Age at first dose
- 66+
- ZIP prefix
- 452 / OH
- Registered
- 2021-01-28
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-27
Dose 1 — Moderna
-
2021-01-28
Registered in v-safe
- 2021-01-28
-
2021-01-29
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-01-30
-
2021-01-31
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Joint pains, Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-02-01
- 2021-02-02
-
2021-02-03
Survey response — day 7, dose 1MedDRA: Unevaluable event, Visual impairment — Feeling: Good · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Systemic reaction (other): Vision problems · Healthcare visit (other): Made appointment with ophthalmologistMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-03
Report sent to call center — day 7, dose 1Get care from a doctor or other healthcare professional1 call case(s)
- 2021-02-10
- 2021-02-17
-
2021-02-24
Dose 2 — Moderna
- 2021-02-24
-
2021-02-25
Survey response — days 1–6 daily, dose 2MedDRA: Ear pain, Oropharyngeal pain — Feeling: Fair · Site: Pain · Joint pains, Muscle or body achesFree text: Mild sore throat and ear acheMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-26
Survey response — days 1–6 daily, dose 2MedDRA: Adverse reaction — Feeling: Fair · Site: Pain · Chills, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: These symptoms were last night, beginning after I had answered yesterdays questionsMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-27
- 2021-02-28
- 2021-03-01
- 2021-03-02
- 2021-03-05
- 2021-03-10
- 2021-03-17
- 2021-03-24
- 2021-03-31
- 2021-04-07
- 2021-05-28
- 2021-06-24
- 2021-08-25
-
2022-02-01
Dose 3 — Moderna
- 2022-02-24
-
2022-05-11
Dose 4 — Moderna
- 2022-05-11
- 2022-05-12
- 2022-05-13
- 2022-05-14
- 2022-05-15
- 2022-05-16
- 2022-05-17
- 2022-05-18
- 2022-05-25
- 2022-06-01
- 2022-06-08
- 2022-06-15
- 2022-06-22
-
2022-08-10
Survey response — 3 months, dose 4MedDRA: Intermenstrual bleeding, Office visit, Polyp, Postmenopausal haemorrhage — Feeling: Good · Get care from a doctor or other healthcare professionalFree text: Symptoms: On 5/11 two days after second booster I began post menopausal breakthrough bleeding I did not report it to you at the time because I thought it was unrelated. Have since read otherwise · Healthcare visit (other): Urogynecologist (benign polyps)MedDRA releases: 2024-11 · check-in free text available
-
2022-08-10
Report sent to call center — 3 months, dose 4Get care from a doctor or other healthcare professional1 call case(s)
-
2022-08-17
Call successfulCompleted over the phone
-
2022-10-10
Dose 5 — Moderna
-
2022-10-11
Health check-in — days 1–6 daily, dose 5Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2022-10-12
- 2022-10-13
- 2022-10-14
- 2022-10-15
- 2022-10-17
-
2022-10-24
Survey response — day 14, dose 5MedDRA: Back pain, Pain, Pain in extremity — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Back pain During the night radiating into my leg and still ongoing periodically. This same pain began a couple of weeks after my previous Covid booster.MedDRA releases: 2024-11 · check-in free text available
- 2022-10-31
- 2022-11-07
- 2022-11-14
- 2022-11-22
-
2023-01-09
Survey response — 3 months, dose 5MedDRA: COVID-19, Irritable bowel syndrome, Office visit, Unevaluable event — Feeling: Poor · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professionalMedDRA releases: 2024-11
-
2023-01-09
Report sent to call center — 3 months, dose 5Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
-
2023-01-10
Call successfulDoes not wish to fill out VAERS report
-
2023-04-12
Survey response — 6 months, dose 5MedDRA: Eye infection, Office visit, Skin laceration — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professionalMedDRA releases: 2024-11
-
2023-04-12
Report sent to call center — 6 months, dose 5Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
- 2023-04-13
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-27 | Moderna | |
| 2 | 2021-02-24 | Moderna | |
| 3 | 2022-02-01 | Moderna | No |
| 4 | 2022-05-11 | Moderna | No |
| 5 | 2022-10-10 | Moderna | No |
Call center
4 call center cases
3 successful · 1 unsuccessful
VAERS report filed, before or during a call: 1
1 wait over 3 months for a first call
Free text
Release 3 — day 7, dose 1
Systemic reaction (other): Vision problems
Healthcare visit (other): Made appointment with ophthalmologist
Release 4 — days 1–6 daily, dose 2
Systemic reaction (other): Mild sore throat and ear ache
Systemic reaction (other): These symptoms were last night, beginning after I had answered yesterdays questions
Release 12 — 3 months, dose 4
Symptoms: On 5/11 two days after second booster I began post menopausal breakthrough bleeding I did not report it to you at the time because I thought it was unrelated. Have since read otherwise
Healthcare visit (other): Urogynecologist (benign polyps)
Release 12 — day 14, dose 5
Symptoms: Back pain During the night radiating into my leg and still ongoing periodically. This same pain began a couple of weeks after my previous Covid booster.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Office visit | · | · | ✓ |
| HCVO | Polyp | · | · | ✓ |
| HCVO | Unevaluable event | ✓ | ✓ | ✓ |
| SD | Back pain | · | · | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SD | Eye infection | · | · | ✓ |
| SD | Intermenstrual bleeding | · | · | ✓ |
| SD | Irritable bowel syndrome | · | · | ✓ |
| SD | Pain | · | · | ✓ |
| SD | Pain in extremity | · | · | ✓ |
| SD | Postmenopausal haemorrhage | · | · | ✓ |
| SD | Skin laceration | · | · | ✓ |
| SD | Unevaluable event | · | · | ✓ |
| SRO | Adverse reaction | ✓ | ✓ | ✓ |
| SRO | Ear pain | ✓ | ✓ | ✓ |
| SRO | Oropharyngeal pain | ✓ | ✓ | ✓ |
| SRO | Visual impairment | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release